<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04498351</url>
  </required_header>
  <id_info>
    <org_study_id>N-19-2020</org_study_id>
    <nct_id>NCT04498351</nct_id>
  </id_info>
  <brief_title>Magnesium Sulfate in Combination With Dexmedetomidine As Adjuvants to Levobupivacaine</brief_title>
  <official_title>Evaluation of Magnesium Sulfate in Combination With Dexmedetomidine As Adjuvants to Levobupivacaine for Augmenting Analgesia and Anesthesia in Ultrasound Guided Spermatic Cord Block For Testicular Sperm Extraction Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Using the spermatic cord block has been of great advantage, as it has been cost saving,&#xD;
      efficient technique whether used inon its own or combination with a sedative or .&#xD;
      Furthermore, it provides minimal cardiac risks, early case ambulation, satisfactory&#xD;
      postoperative pain control, as well as a reduced hospital stay and cost. one of the major&#xD;
      drawbacks of spermatic cord block is being a single injection technique, leading to a short&#xD;
      postoperative analgesia duration. So, to overcome this flaw some adjuvants were proven to&#xD;
      prolong the analgesia duration as Dexmetedomidine (Dex), and magnesium.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The technique of the spermatic cord block was first described in the 1960s by Earle AS.Using&#xD;
      the spermatic cord block has been of great advantage, as it has been cost saving, efficient&#xD;
      technique whether used inon its own or combination with a sedative or . Furthermore, it&#xD;
      provides minimal cardiac risks, early case ambulation, satisfactory postoperative pain&#xD;
      control, as well as a reduced hospital stay and cost. one of the major drawbacks of spermatic&#xD;
      cord block is being a single injection technique, leading to a short postoperative analgesia&#xD;
      duration. So, to overcome this flaw some adjuvants were proven to prolong the analgesia&#xD;
      duration as Dexmetedomidine (Dex), and magnesium.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">April 30, 2020</start_date>
  <completion_date type="Anticipated">March 22, 2021</completion_date>
  <primary_completion_date type="Actual">February 20, 2021</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Following skin sterilization and local anesthetic infiltration of the superficial tissues, an echogenic 22-G block needle is inserted in-plane to the ultrasound beam in a cranial-to-caudal direction the spermatic cord in short axis and directed towards the deferent duct, contralateral to the testicular artery. The needle tip was advanced to become contact with the deferent. Correct location of the needle tip was confirmed by injecting 0.5-1 ml to see the local anesthetic spreading around the deferent duct. A total of 18ml levobupivacaine 0.5% are then injected into the spermatic cord block .&#xD;
The procedure is repeated on the contralateral side.</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>Prospective randomized double blinded clinical study on humans</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Time from injection of LA to the first postoperative analgesic request</measure>
    <time_frame>UP TO 1 HOURE</time_frame>
    <description>(duration of the block).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>heart rate</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>beat/min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>0 No Pain 1-3 Mild Pain (nagging, annoying, interfering little with ADLs) 4-6 Moderate Pain (interferes significantly with ADLs) 7-10 Severe Pain (disabling; unable to perform ADLs)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>perform SCAB</measure>
    <time_frame>UP TO 1 HOURE</time_frame>
    <description>The mean time needed to perform SCAB</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>total nalbuphine consumption</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>total nalbuphine consumption</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of complications</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mean arterial blood pressure</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>mmHg</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Spermatic Cord Block</condition>
  <arm_group>
    <arm_group_label>cotrol group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>dexmedetomidine group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>magnesium sulphate group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>dexmedetomidine and magnesium sulphate group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Control Test</intervention_name>
    <description>Spermatic cord block by18ml levobupivacaine 0.5% plus 2 ml normal saline in total volume of 20 ml.&#xD;
The procedure is repeated on the contralateral side.</description>
    <arm_group_label>cotrol group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Spermatic cord block by total of 18ml levobupivacaine 0.5% plus 1 μg/kg dexmedetomidine in 2 ml in total volume of 20 ml The procedure is repeated on the contralateral side.</description>
    <arm_group_label>dexmedetomidine group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine and magnesium sulphate</intervention_name>
    <description>Spermatic cord block by total of 18ml levobupivacaine 0.5% plus 1 μg/kg dexmedetomidine and 100 mg magnesium sulphate in 2 ml in total volume of 20 ml .&#xD;
The procedure is repeated on the contralateral side.</description>
    <arm_group_label>dexmedetomidine and magnesium sulphate group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>magnesium sulphate</intervention_name>
    <description>Spermatic cord block by total of 18ml levobupivacaine 0.5% plus 100 mg magnesium sulphate in 2 ml in total volume of 20 ml</description>
    <arm_group_label>magnesium sulphate group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged from 18 to 60 years.&#xD;
&#xD;
          -  ASA I-II.&#xD;
&#xD;
          -  Undergoing Testicular Sperm Extraction Surgery.&#xD;
&#xD;
          -  BMI from 18.5 to 30 kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient refusal&#xD;
&#xD;
          -  Contraindications to regional anesthesia (bleeding disorders e.g. INR&gt;1.5, PC&lt;70%,&#xD;
             platelet count&lt;100 × 109, use of any anti-coagulants, local infection, etc.).&#xD;
&#xD;
          -  Known allergy to local anesthetics.&#xD;
&#xD;
          -  ASA III-IV.&#xD;
&#xD;
          -  Patients aged less than 18 or more than 60.&#xD;
&#xD;
          -  Body mass index &gt;35.&#xD;
&#xD;
          -  Patients with difficulty in evaluating their level of pain.&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>the operation only in male</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>mohamad abdulfatah, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>lecture</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Medicine, Cairo University.</name>
      <address>
        <city>Cairo</city>
        <zip>11451</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>July 28, 2020</study_first_submitted>
  <study_first_submitted_qc>July 31, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 4, 2020</study_first_posted>
  <last_update_submitted>March 9, 2021</last_update_submitted>
  <last_update_submitted_qc>March 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Amr Samir Wahdan</investigator_full_name>
    <investigator_title>Lecturer of Anesthesia, Pain management and Surgical ICU</investigator_title>
  </responsible_party>
  <keyword>Spermatic Cord Block</keyword>
  <keyword>Magnesium Sulfate</keyword>
  <keyword>Dexmedetomidine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Magnesium Sulfate</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>still working</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

